Symrise Aktie
WKN DE: SYM999 / ISIN: DE000SYM9999
|
30.07.2025 07:35:04
|
EQS-News: Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care
|
EQS-News: Symrise AG
/ Key word(s): Personnel
Press release
The Supervisory Board of Symrise AG has appointed Michael Friede to the Executive Board. He will take over as President of the Scent & Care segment, which was ad-interim headed by CEO Dr. Jean-Yves Parisot. The Scent & Care segment, comprising Symrise's activities in fragrance applications, aroma molecules and cosmetic ingredients, generates annual sales of approximately EUR 2 billion. Michael König, Chairman of the Supervisory Board of Symrise AG: "We are very pleased to announce that Michael Friede will join us as a member of the Executive Board. He brings many years of broad market knowledge and a high level of industry-specific expertise in various growth areas. Additionally, he has proven international experience, making him an excellent choice for Symrise as a fast-growing, globally operating company." Michael Friede has been a member of the Management Board of Brenntag SE, Essen, Germany, since 2023, where he served as CEO of Brenntag Specialties leading the Life Science and Material Science specialty chemicals segments globally. Previously, he was a member of the Executive Committee of Akzo Nobel N.V. Amsterdam, the Netherlands, Executive Vice President at Covestro AG, Germany, and CEO and President of Covestro Elastomers SAS in France. He began his professional career at Bayer AG, where he held various management positions in Leverkusen, Germany, and Pittsburgh, USA. In addition, he is a Supervisory Board member of Pearl Polyurethane Systems LLC, a leading producer of polyurethane systems, headquartered in Dubai. Michael Friede (born in 1980), grew up in the county of Holzminden in southern Lower Saxony, studied in Madrid, Toronto, Essen, Oxford and London and holds both, a Master of Business Administration and a Bachelor of Science in Business Administration. He is married and has three children.
About Symrise: Symrise is a global supplier of fragrances and flavors, cosmetic active ingredients as well as functional ingredients. Its customers include perfume, cosmetics, food and beverage manufacturers, the pharmaceutical industry and producers of dietary supplements and pet food. With sales of around €5 billion in the 2024 financial year, the company is one of the world's leading providers. The Group, headquartered in Holzminden, Germany, has more than 100 locations in Europe, Africa and the Middle East, Asia, North and Latin America. Together with its customers, Symrise develops new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...
30.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Symrise AG |
| Mühlenfeldstraße 1 | |
| 37603 Holzminden | |
| Germany | |
| Phone: | +49 (0)5531 90 0 |
| E-mail: | ir@symrise.com |
| Internet: | www.symrise.com |
| ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
| WKN: | SYM999 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2176338 |
| End of News | EQS News Service |
|
|
2176338 30.07.2025 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Symrise AGmehr Nachrichten
|
07.11.25 |
EQS-PVR: Symrise AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group) | |
|
07.11.25 |
Minuszeichen in Frankfurt: LUS-DAX in der Verlustzone (finanzen.at) | |
|
07.11.25 |
XETRA-Handel DAX verbucht nachmittags Verluste (finanzen.at) | |
|
07.11.25 |
DAX 40-Wert Symrise-Aktie: So viel Gewinn hätte eine Symrise-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
|
07.11.25 |
Buy für Symrise-Aktie nach UBS AG-Analyse (finanzen.at) | |
|
06.11.25 |
EQS-DD: Symrise AG: Walter Ribeiro, Kauf (EQS Group) | |
|
05.11.25 |
XETRA-Handel LUS-DAX fällt mittags zurück (finanzen.at) | |
|
05.11.25 |
Minuszeichen in Frankfurt: DAX zeigt sich am Mittwochmittag schwächer (finanzen.at) |
Analysen zu Symrise AGmehr Analysen
| 07.11.25 | Symrise Buy | UBS AG | |
| 05.11.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Symrise Kaufen | DZ BANK | |
| 29.10.25 | Symrise Buy | Deutsche Bank AG | |
| 29.10.25 | Symrise Buy | UBS AG |
Aktien in diesem Artikel
| Symrise AG | 72,66 | 1,42% |
|